Exametazime is a lipophilic amine oxime chelating agent primarily used in nuclear medicine for the preparation of technetium-99m labeled radiopharmaceuticals. This compound acts as a diagnostic imaging… Read more
Exametazime is a lipophilic amine oxime chelating agent primarily used in nuclear medicine for the preparation of technetium-99m labeled radiopharmaceuticals. This compound acts as a diagnostic imaging agent, facilitating the visualization of cerebral blood flow and the detection of inflammatory processes. Laboratories rely on high-quality reference standards, including the active pharmaceutical ingredient, to ensure the accuracy and reliability of analytical testing during quality control and method validation procedures. The category encompasses a range of essential analytical tools, such as identified process-related impurities like N-nitroso exametazime and stable isotope labelled compounds. These materials are critical for impurity profiling, allowing analysts to accurately quantify degradation products and monitor the purity of radiopharmaceutical formulations throughout their shelf life and clinical preparation, ultimately supporting rigorous regulatory compliance and diagnostic precision.